Regeneron Pharmaceuticals | REGN - Ebitda





Ebitda Cambiamento Data
AbbVie USD 6.91B 3.22B 2026-06
Agenus USD -10.11M 19.02M 2025-03
Agios Pharmaceuticals USD -108.66M 11.65M 2026-03
Alnylam Pharmaceuticals USD 360.27M 114.93M 2026-09
Amgen USD 3.86B 1.28B 2026-03
Astellas Pharma JPY 235.24B 136.32B 2026-06
AstraZeneca USD 7.46B 2.3B 2026-09
Biogen USD 450.8M 198.9M 2026-06
BioMarin Pharmaceutical USD 146.05M 170.22M 2026-03
Bristol-Myers Squibb USD 3.48B 1.6B 2026-09
Eli Lilly USD 9.46B 3.54B 2026-09
Gilead Sciences USD -9.31B 12.82B 2026-06
GlaxoSmithKline GBP 3.51B 734M 2026-06
Incyte USD 778.57M 410.6M 2026-06
Ionis Pharmaceuticals USD -64.53M 135.49M 2026-03
J&J USD 8.99B 721M 2026-06
Kyowa Hakko Kirin JPY 53.91B 36.74B 2026-06
Merck USD 1.42B 2.97B 2026-06
Moderna USD -1.26B 468M 2026-03
Neurocrine Biosciences USD 193.3M 25.1M 2026-03
Novartis USD 8.62B 2.14B 2026-09
Novartis USD 5.41B 431M 2026-03
Pfizer USD 6.01B 18M 2026-06
Puma Biotechnology USD 729K 11.36M 2024-06
Regeneron Pharmaceuticals USD 1.66B 695.2M 2026-06
Roche Holding CHF 13.43B 744M 2026-06
Sanofi EUR 2.72B 2.94B 2026-03
Sarepta Therapeutics USD 375.48M 627.68M 2026-03
Teva Pharmaceutical Industries USD 474M 581M 2026-06
Ultragenyx Pharmaceutical USD -155M 55.57M 2026-03
United Therapeutics USD 355M 11.1M 2026-06
Vertex Pharmaceuticals USD 1.33B 130.5M 2026-06